- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about UK:GSK
Recent news which mentions UK:GSK
Tags
UK:GSK
From MarketWatch
Bellus Health’s stock climbs on GSK deal, while Goldman Sachs is hurt by a revenue miss
April 18, 2023
From MarketWatch
GSK to acquire U.S.-based BELLUS Health for $14.75 per share
April 18, 2023
From MarketWatch
GSK reports positive phase 3 data for UTI oral antibiotic
April 17, 2023
Tags
UK:GSK
From MarketWatch
FTSE 100 hits fresh record above 8,000 on weak pound and renewed demand for energy stocks
February 16, 2023
From MarketWatch
GSK posts higher sales and profit of $1.85 billion, lifted by specialty medicines and vaccines businesses
February 01, 2023
Tickers
GSK
From MarketWatch
Moderna is the latest company to produce a promising RSV vaccine
January 18, 2023
From MarketWatch
Moderna, CureVac and Ocugen offer updates on COVID vaccines, while China cracks down on critics of government’s pandemic response
January 09, 2023
From MarketWatch
Get ready for a ‘conundrum’ of a respiratory illness season
December 07, 2022
Tickers
PFE
From MarketWatch
Tickers
GSK
From MarketWatch
GSK to withdraw Blenrep’s U.S. marketing authorization after FDA request
November 22, 2022
Tags
UK:GSK
From MarketWatch
China eases some travel requirements in move welcomed by markets, even as it counts 10,000 new COVID cases in a day
November 11, 2022
Tickers
GSK
From MarketWatch
From MarketWatch
Tickers
GSK
From MarketWatch
Tickers
GSK
From MarketWatch
Tags
UK:GSK
From MarketWatch
From MarketWatch
AstraZeneca, Eli Lilly and Roche among pharmaceutical companies upgraded for high returns on R&D investments, analysts say
September 14, 2022
From MarketWatch
From MarketWatch
GSK defends Zantac ahead of trials that have cratered the stock
August 12, 2022
From MarketWatch
Tags
UK:GSK
From MarketWatch
From MarketWatch
Tickers
GSK
From MarketWatch
GlaxoSmithKline to buy Sierra Oncology for $1.9 billion
April 13, 2022
From MarketWatch
BA.2 subvariant of omicron accounted for almost 94% of global cases in latest week in latest sign of how dominant it has become
April 06, 2022
From MarketWatch
WHO urges countries to keep up COVID-19 testing and surveillance as the virus is still a global pandemic
March 30, 2022
From MarketWatch
CDC expected to loosen COVID face-mask advice later Friday, and Canada authorizes first plant-based vaccine
February 25, 2022
Tickers
GSK
From MarketWatch
WHO says omicron subvariant is not stopping global cases from falling, and U.S. nearing 940,000 COVID deaths
February 23, 2022
From MarketWatch
From MarketWatch
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.